Pie Medical Imaging BV (PMI) announced today that they have signed an agreement with the Cardiovascular Research Foundation (CRF) to begin a close collaboration.
Pie Medical Imaging BV (PMI) announced today that they have signed an agreement with the Cardiovascular Research Foundation (CRF) to begin a close collaboration. Under this agreement the CRF Clinical Trials Center will use PMI’s solutions in their Angiographic Core Laboratory for clinical research and multi-center trials. As part of the agreement, CRF will also support further development of PMI’s new state-of-the-art products for analysis and visualization of medical images. The CRF Clinical Trials Center (CTC) plans and executes clinical investigations from first-in-man studies to large, multicenter, international trials and provides expert, independent qualitative and quantitative analyses of clinical and imaging data.
“We selected PMI for its well renowned software solutions for clinical trials and research in the areas of interventional cardiology, endovascular medicine and structural heart disease, as well as their ongoing and groundbreaking developments in the field of cardiovascular imaging solutions,” said Philippe Genereux, MD, Director of Angiographic Core Laboratory at the CRF Clinical Trials Center.
“PMI is pleased to work with CRF, a highly recognized international research and educational institution. Our collaboration with CRF gives PMI the opportunity to leverage CRF’s knowledge to further enhance our products and in ongoing development of new state-of-the-art solutions,” said Boudewijn Verstraelen, CEO at PMI.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.